Usefulness of molecular markers in the diagnosis of occupational and recreational histoplasmosis outbreaks

. 2017 Mar ; 62 (2) : 111-116. [epub] 20161010

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid27726064
Odkazy

PubMed 27726064
DOI 10.1007/s12223-016-0477-4
PII: 10.1007/s12223-016-0477-4
Knihovny.cz E-zdroje

Histoplasmosis is considered the most important systemic mycosis in Mexico, and its diagnosis requires fast and reliable methodologies. The present study evaluated the usefulness of PCR using Hcp100 and 1281-1283(220) molecular markers in detecting Histoplasma capsulatum in occupational and recreational outbreaks. Seven clinical serum samples of infected individuals from three different histoplasmosis outbreaks were processed by enzyme-linked immunosorbent assay (ELISA) to titre anti-H. capsulatum antibodies and to extract DNA. Fourteen environmental samples were also processed for H. capsulatum isolation and DNA extraction. Both clinical and environmental DNA samples were analysed by PCR with Hcp100 and 1281-1283(220) markers. Antibodies to H. capsulatum were detected by ELISA in all serum samples using specific antigens, and in six of these samples, the PCR products of both molecular markers were amplified. Four environmental samples amplified one of the two markers, but only one sample amplified both markers and an isolate of H. capsulatum was cultured from this sample. All PCR products were sequenced, and the sequences for each marker were analysed using the Basic Local Alignment Search Tool (BLASTn), which revealed 95-98 and 98-100 % similarities with the reference sequences deposited in the GenBank for Hcp100 and 1281-1283(220), respectively. Both molecular markers proved to be useful in studying histoplasmosis outbreaks because they are matched for pathogen detection in either clinical or environmental samples.

Zobrazit více v PubMed

Gac Med Mex. 2011 Sep-Oct;147(5):377-84 PubMed

Diagn Microbiol Infect Dis. 2006 Apr;54(4):283-7 PubMed

J Clin Microbiol. 2003 Apr;41(4):1753-5 PubMed

Mycoses. 1996 Sep-Oct;39(9-10):375-9 PubMed

Clin Microbiol Infect. 2016 Sep;22(9):810.e1-810.e8 PubMed

J Clin Microbiol. 2014 Apr;52(4):1168-76 PubMed

Rev Iberoam Micol. 2013 Jul-Sep;30(3):193-9 PubMed

Am J Trop Med Hyg. 1999 Dec;61(6):914-9 PubMed

J Clin Microbiol. 2003 Mar;41(3):1295-8 PubMed

J Clin Microbiol. 2002 May;40(5):1644-7 PubMed

An Bras Dermatol. 2013 Jan-Feb;88(1):141-3 PubMed

Rev Iberoam Micol. 2012 Jul-Sep;29(3):115-9 PubMed

Rev Iberoam Micol. 2013 Oct-Dec;30(4):256-60 PubMed

J Med Vet Mycol. 1995 Sep-Oct;33(5):319-25 PubMed

J Clin Microbiol. 2003 Feb;41(2):535-9 PubMed

FEMS Immunol Med Microbiol. 2005 Sep 1;45(3):435-41 PubMed

BMC Infect Dis. 2010 Sep 08;10:264 PubMed

Clin Vaccine Immunol. 2010 Jan;17(1):62-7 PubMed

Vet Microbiol. 2003 Jul 17;94(3):219-24 PubMed

Emerg Infect Dis. 2006 Jan;12(1):163-5 PubMed

J Clin Microbiol. 2012 Mar;50(3):673-9 PubMed

FEMS Immunol Med Microbiol. 2005 Sep 1;45(3):451-8 PubMed

Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...